期刊文献+

T幼淋巴细胞白血病1例并文献复习 被引量:1

下载PDF
导出
摘要 T幼淋巴细胞白血病(T-PLL)是一种罕见的侵袭性成熟T淋巴细胞白血病,具有独特的细胞形态学、免疫分型、细胞遗传学及分子生物学特征,约占成人成熟淋巴细胞白血病的2%,疾病呈进展性,患者中位生存时间通常小于1年~[1]。TPLL在临床少见,国内外对该病的报道有限,现本文对1例TPLL患者进行报道并结合文献进行复习。
出处 《国际检验医学杂志》 CAS 2015年第23期3505-3506,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献9

  • 1SwerdlowSH,CampoE,HarrisNI.,eta1.周小鸽,陈辉树(译).造血与淋巴组织肿瘤WHO分类[M].4版(下册).北京:诊断病理学杂志社,2011:497-499. 被引量:1
  • 2Dearden CE. T-Cell prolymphocytic leukemia[J]. Clin Lymphoma Myeloma,2009,9(Suppl 3) :$239-243. 被引量:1
  • 3章艳茹,齐军元,刘慧敏,刘薇,黄文阳,邓书会,易树华,徐燕,李增军,傅明伟,邹德慧,赵耀中,邱录贵.中国T幼淋巴细胞白血病临床及实验室特征[J].中华血液学杂志,2013,34(10):839-843. 被引量:7
  • 4Bergmann AK,Schneppenheim S,Seifert M,et al. Recurrent mu- tation of JAK3 in T cell prolymphocytic leukemia[J]. Genes Chromosomes Cancer,2014,53(4) = 309-316. 被引量:1
  • 5Kawai H, Matsushita H, Suzuki R, et al. Functional analysis of the SEPT9-ABL1 chimeric fusion gene derived from T-prolym- phocytic leukemia[J]. Leuk Res,2014,38(12) 1451-1459. 被引量:1
  • 6Dearden CE,Matutes E,Cazin B,et al. High remission rate in T- cell prolymphocytlc leukemia with CAMPATH-1H[J]. Blood, 2001,98(6) = 1721-1726. 被引量:1
  • 7Dearden CE, Khot A, Else M, et al. Alemtuzumab therapy in T cell prolymphocytic leukemia= comparing efficacy in a series trea- ted intravenously and a study piloting the subcutaneous route[J]. Blood,2011,118(22) = 5799-5802. 被引量:1
  • 8Wiktor-Jedrzejczak W,Dearden C,De Wreede L, et al. Hemato- poietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Mar- row Transplantation and the Royal Marsden Consortium [J]. Leukemia,2012,26(5), 972 976. 被引量:1
  • 9Krishnan B,Else M,Tjonnfjord GE,et al. Stem cell transplanta tion after a[emtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study[J]. Br J Haematol, 2010,149 (6) 907-910. 被引量:1

二级参考文献13

  • 1Dearden C. How I treat prolymphocytic leukemia. Blood, 2012, 120: 538-551. 被引量:1
  • 2Matures E. Novel and emerging drugs for rarer chronic lymphoid leukaemias. Curr Cancer Drug Targets, 2012, 12: 484-504. 被引量:1
  • 3Dungarwalla M, Mamtes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol, 2008, 80: 469-476. 被引量:1
  • 4Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood, 1991,78: 3269-3274. 被引量:1
  • 5Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood, 1995, 86:1163-1169. 被引量:1
  • 6Kameoka J, Takahashi N, Noji H, et al. T-cell prolymphocytic leukemia in Japan: is it avariant?. Int J Hematol, 2012, 95: 660-667. 被引量:1
  • 7Takizawa M, Matsushima T, Yokohama A, et al. Unclassified mature T cell leukemia with cerebriform nuclei. Rinsho Ketsueki, 2005, 46:486-491. 被引量:1
  • 8Kussick S J, Wood BL, Sabath DE. Mature T cell leukemias which cannot be adequately classified under the new WHO classification of lymphoid neoplasms. Leukemia, 2002, 16: 2457-2458. 被引量:1
  • 9Matutes E, Catovsky D. Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T- prolymphocytic leukemia. Blood, 1996, 87:3520-3521. 被引量:1
  • 10Matutes E, Catovsky D. Classification of mature T-cell leuke- mias. Leukemia, 2003,17:1682-1683. 被引量:1

共引文献6

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部